APA

Mann J. E., Hoesli R., Michmerhuizen N. L., Devenport S. N., Ludwig M. L., Vandenberg T. R., Matovina C., Jawad N., Mierzwa M., Shuman A. G., Spector M. E. & Brenner J. C. (2017). Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. : Journal of Cancer.

Chicago

Mann J E, Hoesli R, Michmerhuizen N L, Devenport S N, Ludwig M L, Vandenberg T R, Matovina C, Jawad N, Mierzwa M, Shuman A G, Spector M E and Brenner J C. 2017. Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. : Journal of Cancer.

Harvard

Mann J. E., Hoesli R., Michmerhuizen N. L., Devenport S. N., Ludwig M. L., Vandenberg T. R., Matovina C., Jawad N., Mierzwa M., Shuman A. G., Spector M. E. and Brenner J. C. (2017). Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. : Journal of Cancer.

MLA

Mann J E, Hoesli R, Michmerhuizen N L, Devenport S N, Ludwig M L, Vandenberg T R, Matovina C, Jawad N, Mierzwa M, Shuman A G, Spector M E and Brenner J C. Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. : Journal of Cancer. 2017.